NCT04407559 - COVID-SErology in Rheumatoid Arthritis (COVID-19) | Biotech Hunter

Enrollment

216

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

September 1, 2020

Study Completion Date

September 30, 2020

Conditions

COVID-19Rheumatoid Arthritis

Interventions

OTHER

Serological analyses to be lead on a pre-existing biobank

"3 immunoassays will be used according to the procedure described (Demey-2020; Tuaillon-2020) :~* WuHan UNscience Biotechnology Co., Ltd (Chine). COVID-19 IgG/IgM Rapid Test Kit, (Wuhan, China), will be refered as UNscience~* Chongqing iSIA BIO-Technology Co., Ltd (Chine). 2019-nCoV IgM/IgG Diagnostic Test Kit ; (Chongqing, China), will be refered as iSIA~* Xiamen Biotime Biotechnology Co. Ldt (Chine). (SARS-CoV-2) IgM/IgG Rapid Qualitative Test Kit, will be refered as Biotime."

Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors

lead

University Hospital, Montpellier

OTHER